PrEP research: Why pregnant, lactating women shouldn’t be excluded – Expert

PrEP research: Why pregnant, lactating women shouldn’t be excluded – Expert

The Executive Director of New HIV Vaccine and Microbicide Advocacy Society (NHVMAS), Mrs Florita Durueke, has called for the inclusion of pregnant and lactating women in the HIV clinical trial intervention for pre-exposure prophylaxis (PrEP) saying their involvement would help in the reduction of HIV as they face substantial risk of HIV infection. 

Speaking in one of the just concluded five-day webinar series by the organisation, Durueke recalled that  there is a growing consensus globally around the ethical and public health imperative for the responsible inclusion of pregnant women and lactating mothers in clinical research.

She said: “there is a need to develop ethics guidelines for the inclusion of pregnant women and lactating mothers in HIV/co-infections research.

“World Health Organisation, WHO, in partnership with MPACT has identified these gaps and they have developed a framework that stipulates that pregnant women and breastfeeding mothers can participate in research, especially at the face two. They design a situation that if a woman is faced with two trials, at the cost of the trial becoming pregnant she discontinues.

“When we did the trial in Lagos, one of the criteria is that you are not going to get pregnant for that period, so if the person gets pregnant she will discontinue.

“But the WHO framework is saying when a person gets pregnant in an HIV prevention trial, they should offer the person the opportunity to decide if she is willing to continue in the research and if the person says yes, then they should allow the person and then collect the data,” Durueke said.

While calling for advanced responsible HIV prevention research in pregnant and lactating populations, PLP, using a Reproductive Justice, she said that there is a need to engage stakeholders in an early, sustained, and meaningful way in designing and conduct a biomedical HIV prevention trials tailored to the distinctive complexities of research with PLP.

She also advocated sound ethics review processes that promote the responsible inclusion of PLP, including adolescent girls and young women, in biomedical HIV prevention research.

About author

You might also like

BREAKING NEWS 0 Comments

Buhari directs best care for released Chibok girls – Minister 

UNFPA pledges psychosocial support, reproductive health services The Minister of Health, Prof Isaac Adewole, says  President Muhammadu Buhari has directed that relevant public institution should ensure that adequate care is

Ebola: WHO Emergency Committee says international spread risk is high

… Says outbreak not yet international Public Health Emergency The first meeting of the Emergency Committee convened by the WHO Director-General, on the Ebola Virus Disease (EVD) outbreak in the

Mental Health Bill: Network commends FG

The Founder, Nigerian Mental Health Network, Mr. Chime Asonye, has commended President Muhammadu Buhari for signing the National Mental Health Bill 2021, into law. He, however, urged incoming administrations to

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply